THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

At Biogen Idec, one of them had to go

Mullen, Icahn had clash of wills

By Robert Weisman
Globe Staff / January 11, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

In the end, Biogen Idec Inc. wasn’t big enough for both Carl C. Icahn and James C. Mullen. (Full article: 1346 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass